Phase I/IIGDC-0973 — solid tumours (C)Paclitaxel — breast cancer and other solid tumours (C)Docetaxel — solid tumours (A)Trastuzumab and pertuzumab — breast cancer (A)Fulvestrant, aromatase inhibitor, and palbociclib — breast cancer (A)mFOLFOX6 (oxaliplatin, leucovorin, 5FU) — gastric cancer and other solid tumours (A)Enzalutamide — gastric cancer and other solid tumours (A)Abiraterone — prostate cancer (A)Rucaparin — breast, ovarian and prostate cancer (A)Carboplatin and paclitaxel — breast cancer (A) Phase 1b/IIIPalbociclib and fulvestrant — breast cancer (A). This evidence concerns the gene CYP19A1 and prostate carcinoma.